2024³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ÃæûÁöȸ ½ÉÆ÷Áö¾ö : 2024-03-30 |
|
2024³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ÃæûÁöȸ ½ÉÆ÷Áö¾ö : 2024-03-30 ±³À°ÁÖÁ¦ : 2024³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ÃæûÁöȸ ½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ´ã´çÀÚ : Çѹμö À̸ÞÀÏ : daonics@naver.com ±³À°Á¾·ù : ¸¶ÃëÅëÁõÀÇÇаú Âü¼®¿¹»óÀÎ : 100¸í Áö¿ª : ´ëÀü±¤¿ª½Ã ¼¼ºÎ¼ö°·á : 50,000¿ø ºñ°í Àü°øÀÇ ¹× ±âŸÀÇ·áÁø 2¸¸¿ø
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 09:00~09:40 Malignant Hyperthermia: A Practical Guide in Korea ÀÓº´°Ç(°í·ÁÀÇ´ë) ±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 09:40~10:20 Anesthesia and Environment ¿À¾Æ¿µ(¼¿ïÀÇ´ë) ÈÞ½Ä 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 10:20~10:35 Break () ±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 10:35~11:00 Efficacy and Safety of Sugammadex in Children À̼ö¹Î(Ãæ³²ÀÇ´ë) ±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 11:00~11:25 Sugammadex in Pregnant Women and Women of Childbearing Age ÀÌÁØÈ£(ÀüºÏÀÇ´ë) Åä·Ð 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 11:25~11:35 Q&A () ±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 11:35~12:00 Neuromuscular Blockade and Its Reversal in Geriatric Population ¼ºÅÂÀ±(°Ç¾çÀÇ´ë) ±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 12:00~12:25 Neuromuscular Blockade and Its Reversal in Musculoskeletal Disorder ÇÑÁö¿ø(Áß¾ÓÀÇ´ë) Åä·Ð 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 12:25~12:35 Q&A () ½Ä»ç 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 12:35~13:35 Lunch () ±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 13:35~14:05 Good Clinical Research Practice (GCRP) in Neuromuscular Research ±¸Ã¢ÈÆ(¼¿ïÀÇ´ë) ±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 14:05~14:35 Common Flaws in Neuromuscular Research Á¤±âÅÂ(Á¶¼±ÀÇ´ë) ±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 14:35~15:05 Unmet needs in Neuromuscular Research ÀÌ»ó¼®(ÀÎÁ¦ÀÇ´ë) Åä·Ð 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:05~15:20 Q&A () ÈÞ½Ä 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:20~15:35 Break () ±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:35~15:50 Resistance or Tachyphylaxis to Rocuronium õº¸¸§(ÇѸ²ÀÇ´ë) ±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:50~16:05 Analysis of characteristics of patients whose sugammadex claims were denied by the Auto Insurance Claims Review Department. Á¶¼ö¿¬(Á¶¼±ÀÇ´ë) ±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 16:05~16:20 Response of adductor longus muscle during obturator nerve block under deep NMB ÇÏÀº±³(Á¶¼±ÀÇ´ë) ±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 16:20~16:35 Comparison of effects of sugammadex administration timing on the success rate of neuromuscular monitoring before extubation and recovery profile in patients undergoing general anesthesia À̱Կø(°Ç¾çÀÇ´ë) ±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 16:35~16:50 Rocuronium induced anaphylaxis in robotic hysterectomy À̵¿±Ù(Ãæ³²ÀÇ´ë)
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|